Literature DB >> 11933188

An update on conformation sensitive gel electrophoresis.

Arupa Ganguly1.   

Abstract

Conformation-sensitive gel electrophoresis (CSGE) was developed as a method of heteroduplex analysis to screen large multi-exon genes for sequence variation. The novelty of the method was in the use of a non-proprietary acrylamide gel matrix that used 1,4-bis (acrolyl) piperazine (BAP) as a cross linker with ethylene glycol and formamide as mildly denaturing solvents. The denaturing environment enhances the conformation polymorphism present in DNA heteroduplexes containing variations as small as single nucleotide polymorphisms (SNPs). CSGE has also been adapted for use on a fluorescent platform (F-CSGE) that resulted in higher throughput and sensitivity. Variation in sensitivity of CSGE has been studied extensively. The results demonstrate that the nature of the mismatched base in a defined sequence context has the most profound effect on the conformation of the heteroduplex. Additionally, the size of the PCR product, as well as the location of the mismatch within the PCR product, are two important parameters that determine the resolution of the mismatch-containing heteroduplexes during CSGE. Like any other mutation scanning technique, CSGE can have limited resolution of two closely linked sequence variations. For specific genes, like BRCA1 and BRCA2 where multiple SNPs are present in the coding sequence, each CSGE shift has to be sequenced to define the exact nature of the sequence change. In conclusion, CSGE scanning provides a powerful, cost-efficient way to scan genes with high sensitivity and specificity. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933188     DOI: 10.1002/humu.10059

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  Single nucleotide polymorphism seeking long term association with complex disease.

Authors:  Brian W Kirk; Matthew Feinsod; Reyna Favis; Richard M Kliman; Francis Barany
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

2.  Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.

Authors:  Robert C Bauer; Ayanna O Laney; Rosemarie Smith; Jennifer Gerfen; Jennifer J D Morrissette; Stacy Woyciechowski; Jennifer Garbarini; Kathleen M Loomes; Ian D Krantz; Zsolt Urban; Bruce D Gelb; Elizabeth Goldmuntz; Nancy B Spinner
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

3.  Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.

Authors:  W A Cabral; S Milgrom; A D Letocha; E Moriarty; J C Marini
Journal:  J Med Genet       Date:  2006-08       Impact factor: 6.318

4.  Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.

Authors:  Yacoub A Yousef; Abdelghani Tbakhi; Maysa Al-Hussaini; Ibrahim AlNawaiseh; Ala Saab; Amal Afifi; Maysa Naji; Mona Mohammad; Rasha Deebajah; Imad Jaradat; Iyad Sultan; Mustafa Mehyar
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

5.  Complete gene scanning by temperature gradient capillary electrophoresis using the cystic fibrosis transmembrane conductance regulator gene as a model.

Authors:  Lan-Szu Chou; Friederike Gedge; Elaine Lyon
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

6.  Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

Authors:  Jirina Bartkova; Johanna Tommiska; Lenka Oplustilova; Kirsimari Aaltonen; Anitta Tamminen; Tuomas Heikkinen; Martin Mistrik; Kristiina Aittomäki; Carl Blomqvist; Päivi Heikkilä; Jiri Lukas; Heli Nevanlinna; Jiri Bartek
Journal:  Mol Oncol       Date:  2008-10-07       Impact factor: 6.603

7.  Genetic aberrations and survival in plasma cell leukemia.

Authors:  R E Tiedemann; N Gonzalez-Paz; R A Kyle; R Santana-Davila; T Price-Troska; S A Van Wier; W J Chng; R P Ketterling; M A Gertz; K Henderson; P R Greipp; A Dispenzieri; M Q Lacy; S V Rajkumar; P L Bergsagel; A K Stewart; R Fonseca
Journal:  Leukemia       Date:  2008-01-24       Impact factor: 11.528

8.  Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

Authors:  Amy J French; Daniel J Sargent; Lawrence J Burgart; Nathan R Foster; Brian F Kabat; Richard Goldberg; Lois Shepherd; Harold E Windschitl; Stephen N Thibodeau
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

9.  Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters.

Authors:  Adele Schneider; Tanya M Bardakjian; Jie Zhou; Nkecha Hughes; Rosanne Keep; Darnelle Dorsainville; Femida Kherani; James Katowitz; Lisa A Schimmenti; Marybeth Hummel; David R Fitzpatrick; Terri L Young
Journal:  Am J Med Genet A       Date:  2008-11-01       Impact factor: 2.802

10.  Detection of FLT3 oncogene mutations in acute myeloid leukemia using conformation sensitive gel electrophoresis.

Authors:  Mamdooh Gari; Adel Abuzenadah; Adeel Chaudhary; Mohammed Al-Qahtani; Huda Banni; Waseem Ahmad; Fatin Al-Sayes; Sahira Lary; Ghazi Damanhouri
Journal:  Int J Mol Sci       Date:  2008-11-11       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.